Connect with us

CBD

Oil Boom: Cannabis extracts target treatment, eliminate waste in the industry | Cannabis

Published

on

The Weekly brings you the third annual edition of OIL to its readers, celebrating July 10-710, what OIL is on its head – and the cannabis extractions that created a vibrant market for both medical patients and adult users of legal weed in Arizona to have.

Broadly defined, oil is any product made from cannabis flowers that is processed into a concentrated form that can be used for a variety of purposes, including shatter, wax, crumble, hashish, and other distillates.

There are similar CBD oils that are non-intoxicating and used to treat a variety of conditions, commonly sold as tinctures, lotions, or in capsule form or in smokable cartridges.

THC oils are intoxicating oils that are used medicinally or for recreation due to their euphoric effects. Oils fortified with THC can be found in vaporizable solids (dabs), smokable cartridges, tinctures, various edibles, and capsules.

Vaporizer cartridges are a popular use of oils and are similar to e-cigs, but with a pot instead.

With further processing (known as decarboxylation, which essentially allows THC and other compounds to be absorbed into your liver – you can also make ingestible oils to infuse food and drink, or just put in capsules for those who don’t have infused products want to eat.

click to enlarge

Courtesy photo

The shelves of gummy bears in the downtown dispensary in their industrial kitchen.

As the science behind the processes improves, more and more options come onto the market that can treat specific medical symptoms or provide different types of highs to the adult recreational user.

“We will see more state-specific products going forward,” predicted Moe Asnani, owner of the Downtown and D2 Dispensary, one recent afternoon as a monsoon brewed over his Tucson facility. “Our products are becoming more demanding every day.”

Asnani is also the co-founder of iLava, a line of products heavily based on processed cannabis and powered by cutting edge research and development, keeping him on the cutting edge of the latest developments in the industry.

Claire Levenberg, R&D manager for iLAVA and iLAVAHEMP and also director of science operations for Downtown and D2, firmly believes that science can drive future markets and create more options for the consumer and make the world a better place.

Advertising:

“What we’re going to see is a product with more cannabinoids and the ‘entourage effect’,” Levenberg said.

The entourage effect is a theory that different cannabis compounds work together to produce unique effects and benefits. Cannabis contains more than 550 identified chemical compounds, of which more than 100 phytocannabinoids have been identified, including delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). There are also more than 100 aromatic terpenes that, along with other compounds, make therapeutic compounds for numerous conditions such as pain, anxiety, epilepsy, nausea and vomiting, and post-traumatic stress disorder.

“The combination of cannabinoids and phyto-compounds not only allows the consumer’s metabolic processes to function based on the metabolites present, but the combination of multiple cannabinoids will interact synergistically to provide more benefits,” Levenberg said, adding that different combinations have specific responses Used to treat a wider range of people as cannabis affects everyone differently.

The secret ingredient

The distillation process makes concentrates or extracts from plant material. All extracts are concentrates, but not all concentrates are extracts. Extracts are made with solvents such as alcohol or butane, while concentrates are made without solvents and contain rosin, desiccant, or kief.

“We’re very much in tune with the extraction process,” Levenberg said. “It’s an absolute science, so consumers should leave it up to manufacturers who know what they’re doing, so don’t do it at home.”

click to enlarge

Edible infusion process at Copia.  - PHOTO WITH KINDNESS

Courtesy photo

Edible infusion process at Copia.

One of the most popular uses of extracts is in making edibles. Your common gummy bear can either be added to the recipe or sprayed on cannabis oil, a much cheaper method that doesn’t infuse cannabis throughout the product.

Copia, an Arizona-based edible manufacturer, uses the former method to ensure accurate dosing and create a better tasting product for its OGeez branded gums, which are infused and crafted from the ground up.

“The infusion creates a better taste and distributes THC evenly throughout the product to make precisely dosed gummy bears,” said Aron Ruben, Copia Operations Manager. “Some companies buy gummy bears and spray distillate on them. It is inexpensive – in other words: cheap – but you do not know how much this product has been dosed. ”

Ruben added that spray-on distillate can sweat the gums off even while in transit, further reducing the accuracy of the dose, so “you might as well lick the inside of the package.”

“Everyone has a horror story about dosing incorrectly,” he said. “Cannabis is not a package deal: we all take in THC differently, so it’s important to be consistent.”

In addition to targeted treatment and dosage control, another benefit for the industry is the reduction of waste, as the processing of cannabis residues – stems, shakes and cuttings that cannot be sold as flowers – into usable components for each harvest can create added value, a phenomenon Known as “garbage” to gold. ”

“The whole industry came up with a way to use the trim and found that you could extract THC and terpenes,” said Ruben. “Gone are the days of throwing an ounce of weed into a stick of butter.”

The product is also easier to transport as processing weed into distillates produces a higher potency in a smaller package, as most of the flowers available at the local pot shop have a potency of between 10% and 30% while concentrates have a potency of up to 90% can have.

Ruben said Copia will add “RSO” or Rick Simpson’s Oil to the OGeez line, a full-spectrum crude oil used to treat debilitating conditions such as cancer, Parkinson’s and severe body aches that contains 75 to 80% THC.

“I’m looking forward to the future,” said Ruben. “There is a significant amount of distillate products in the state and growers are selling better quality weed to extraction laboratories for better distillates.”

Why we celebrate OIL

In July 2019 the weekly newspaper recognized the Arizona Supreme Court case clarifying the definition of “marijuana” in legislation to include all parts of the plant and resins derived therefrom.

The May 2019 ruling was the result of the case of Rodney Jones, who was arrested in a Prescott hotel in 2013 and charged with possession of cannabis and drug paraphernalia. Police claimed that Jones also had 1.4 grams of hashish in his possession, according to contemporary reports.

Sheila Polk, Yavapai District Attorney who thwarted efforts to legalize marijuana in 2016, argued that the voter-approved rules of the Arizona Medical Marijuana Act of 2010 do not apply to extracts.

The Arizona Court of Appeals agreed with Polk, ruling in the summer of 2018 that the law did not specifically mention hashish, and if that was the intent of the law, it should have been written that way.

But in a unanimous decision the following year, the Arizona Supreme Court overturned the ruling, concluding that patient protection in the AMMA included products made with resins extracted from the plant.

“It is implausible that voters intended to allow patients with these diseases to use marijuana only if they could consume it in the form of dried leaves / flowers,” the court wrote. “Such an interpretation would preclude the use of marijuana as an option for those for whom smoking or consuming those parts of the marijuana plant would be ineffective or impossible.”

The court stated that its interpretation of the law would allow medical patients to treat their complaints with whatever type of pot best suited their needs.

Jones, a medical marijuana card holder whose conviction and sentence were dropped and sealed following the lawsuit, spent more than two years in prison, which he will not get back. However, his case marked a major milestone in cannabis legislation, forcing lawmakers to recognize the will of the people more fully.

As we appreciate the legal process and celebrate Jones’ discharge, cannabis oil in its various forms has become a boon to consumers and producers alike.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

CBD

ASA rules unfavourably towards CBD oil’s immune health supporting role

Published

on

In the presentation for ProLife CBD Oils, the UK company also claimed that the product was beneficial to general well-being and the immune system, which also means that it has been approved by the Food Standards Agency.

In response to the ASA’s ruling, Gemporia said they were unable “to substantiate the claims or to demonstrate that they are approved claims on the UK Nutrition and Health Claims Register (NHC) (the NHC Register). “

The company added that it assumed the products would be allowed to be marketed because a novel food application had been submitted to the FSA.

All references to this were based on this assumption, adding that they misunderstood the context.

Redditch-based Gemporia admitted having violated the Code on all counts and said their future advertising would comply with the Code.

Presentation details

The ad was specifically a 48-minute teleshopping presentation that aired on Jan.

Throughout the presentation, speakers made claims, including from field reports of the benefits of CBD oil, suggesting that the product could relieve pain and chemotherapy-induced nausea.

The presentation also discussed the requirement that CBD products must be registered with the FSA, saying, “… you have the Certificate of Analysis here and the stability report check … everyone has to have it” and “… what they say is anyone who has submitted their application before the deadline allow them to proceed because they have spent the money and tried and you hope that when they have done so they are confident “,

They continued, “… all this UK regulation just happened, a lot of companies can’t even bring you CBD right now because it doesn’t qualify for quality.”

“We always had the quality; we didn’t have to change anything “and” … this quality certificate and all ticks were always there. “

In support of their decision, ASA said the products were still being tested by the FSA and the novel food application process took into account factors other than the quality of the product.

They concluded that the ad “misrepresents the requirements for novel food approval and misleadingly implies that ProLife CBD Oil products have been approved, endorsed, or approved by the FSA.”

Prevents, treats and cures diseases

ASA’s assessment also assumed that consumers understood that the presentation said ProLife CBD oils could help with the medical conditions mentioned in the slides, testimonials, and speakers.

“We concluded that the claims implied that the product was a food that prevented, treated or cured a human disease, which was prohibited by the Code,” they added.

We thought viewers would understand the claim “helps your immune system” to mean that the CBD in the product would help the immune system function effectively.

“The claim was therefore a specific health claim that is not entered in the NHC register and therefore violates the code.

The other claim, “Helps general well-being”, was also considered to be a general health claim that had to be accompanied by a specific approved health claim related to CBD.

However, since there were no approved health claims for CBD, this claim also violated the code.

Continue Reading

CBD

Feds highlight cannabis research barriers (Newsletter: October 26, 2021)

Published

on

TX Delta 8 ban survives first judicial challenge; Top NV Legislators: Feds Must Legalize Marijuana; Psychedelics grants awarded

Sign up to receive the Marijuana Moment newsletter in your inbox every weekday morning. It’s the best way to make sure you know what cannabis stories are running through your day.

Your support makes marijuana moment possible …

Free to read (but not free to produce)! We pride ourselves on our newsletter and coverage we publish at Marijuana Moment and are happy to make them available to you free of charge. But it takes a lot of work and resources to achieve this.

  • P. Aiden Hunt, Editor, Profiles in Legalization: “MarijuanaMoment.net is probably your best source for cannabis policy news. It caters to the same highly specialized audience that I aim for with my own writing; People affected by the details of cannabis policy. Reading the newsletter assures me that I have not missed anything in my own search. “

If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and benefit more readers: https://www.patreon.com/marijuanamoment

/ MOST IMPORTANT THINGS

In a new report from Marijuana Moment, the National Institute on Drug Abuse briefed the House and Senate Budget Committees on how the restrictive status of cannabis in Appendix I can “hamper critical research … or prevent scientists from pursuing such work”.

  • NIDA also told Congress that scientists fail to study the marijuana consumers actually buy from pharmacies “may hinder the study of the health effects of products that individuals use in the real world.”

A Texas judge turned down an initial motion to block regulators’ ban on delta-8 THC from hemp. The case will be retried next month.

Nevadas Assembly Speakers pro tempore wrote a comment extolling the state’s success in regulating marijuana in a “fair and business-friendly setting” – but said that state legalization was needed to “take this work to the next level”.

the Plant Medicine Coalition announced that it has awarded approximately $ 50,000 in grants to support a variety of psychedelics projects – including one to combat “abuse and predatory behavior in herbal medicine circles”.

/ FEDERATION

the White House National Drug Control Policy Office released details of a new drug control strategy between the US and Colombia.

A Federal Court of Justice Will determine whether to reimburse Missouri medical cannabis sales of $ 166,000 confiscated in transit in Kansas.

Majority Leader in the Senate, Chuck Schumer (D-NY) tweeted about moving to New York to clear up previous marijuana convictions, saying, “I’m proud to see NY take this step. And I’m working with @SenBooker & @RonWyden to pass our Cannabis Administration and Opportunity Act to end the marijuana ban, pass criminal law reforms, and undo the harms of the war on drugs at the federal level. “

Representative Dave Joyce (R-OH) tweeted: “Americans in a majority of states, in both red and blue, have voted to pass sensible cannabis reforms. I encourage my colleagues to respect the will of their voters and the rights of their states and to work for these reforms at the federal level. “

/ CONDITIONS

Pennsylvania Governor Tom Wolf (D) tweeted: “We are working on legalizing marijuana in Pennsylvania. In the meantime, let’s pardon marijuana offenses as soon as possible. ”Separately, Democratic candidate for governor Josh Shapiro, currently the attorney general, tweeted, “It is time to legalize marijuana. To regulate and tax it. But let me be clear: we need to clear the records of those who served sentences other than legalization for possessing small amounts of marijuana. That is the way to justice. “

New Jersey Governor Phil Murphy (D) tweeted, “We have brought four new industries to New Jersey – offshore wind, film and television, marijuana, and sports betting. These industries will bring thousands of well-paying jobs to the Garden State. “

Illinois’s The lieutenant governor held a meeting on a cannabis tax-funded grant program.

Florida Democratic gubernatorial candidate Charlie Crist, currently Congressman, tweeted a video of himself speaking of his support for the legalization of marijuana.

Maryland Democratic attorney general candidate Anthony Brown, currently Congressman and former lieutenant governor, promoted his previous work on decriminalizing marijuana.

Connecticuts The House of Representatives minority leader received an award from the prohibition organization Smart Approaches to Marihuana.

the South Dakota The legislature’s preliminary marijuana study committee will meet on Wednesday.

the Massachusetts The Supreme Court agreed to hear a case over the validity of a local ban on the sale of marijuana.

A Virginia The judge defended his detention of a woman who admitted smoking marijuana the day before before testifying against her alleged domestic violence perpetrator.

Oregon The Department of Agriculture is recruiting volunteers to serve as temporary commissioners in the new Oregon Hemp Commission.

Colorado Regulatory agencies approved additional pesticides that can be used on cannabis.

New Mexicos The Department of Agriculture tweeted about a state hemp poll.

Texas Regulators released an updated list of registered hemp laboratories.

West Virginia Regulators will be hosting events next week to enroll patients with medical cannabis.


Marijuana Moment pursues more than 1,200 cannabis, psychedelics, and drug bills in state legislatures and in Congress this year. Patreon backers who have pledged at least $ 25 per month will have access to our interactive maps, charts, and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a Patreon supporter to gain access.

/ LOCAL

Oakland, California Regulators have referred some social equity marijuana licensees to the city’s collections department after defaulting on loans.

/ INTERNATIONAL

India The Union Ministry of Social Justice and Empowerment recommends decriminalizing drug possession.

Canada The Mexican Embassy tweeted, “Hemp seeds are known as #superfoods because of their many health benefits. Hemp can help care for your skin, control sugar levels, and maintain healthy cholesterol levels. “

The Chief Police Constable in Cleveland, Yorkshire, England posted a comment calling for an end to the war on drugs.

A former guernsey The Prime Minister said it was time to legalize marijuana.

/ SCIENCE & HEALTH

A study of more than 100 cannabis samples showed that “Sativa and Indica-labeled samples” genetically indistinct on a genome-wide scale. “

A review of research on adolescent marijuana use found that the “lifelong prevalence of Vaporizing cannabis doubled from 2013 to 2020 (6.1% to 13.6%), consumption in the last 12 months doubled from 2017 to 2020 (7.2% to 13.2%) and the 30-day prevalence of Cannabis vaping increased sevenfold from 2013 to 2020 (1.6.). % to 8.4%). “

/ RESPONSIBILITY, OPINION & ANALYSIS

the Alliance for Drug Policy seeks several positions including a manager of “Drug Market Reform Strategy and Government” and a coordinator of California’s drug decriminalization efforts.

the Tax foundation criticized a voting initiative in Colorado to raise marijuana taxes and use the proceeds to fund educational programs.

the Vermont Cannabis Equity Coalition Recommendations issued to regulators.

/ COMPANIES

A Florida judge one-sided with Leafly Lift regulators’ ban on using third-party apps to order medical cannabis.

MedMen Enterprises Inc. has a new Chief Operating Officer.

Cresco Labs announced that its Social Justice Summer Initiative raised more than $ 250,000 for judicial reform organizations and supported the extermination process of more than 1,000 people with marijuana criminal records.

Many top Wall Street banks discontinue marijuana testing prior to hiring.

/ CULTURE

Lil ‘Kim introduces a cannabis brand.

Make sure to subscribe to receive Marijuana Moment in your inbox every day.

Photo courtesy of Chris Wallis // side pocket images.

Marijuana Moment is made possible with the support of readers. If you rely on our cannabis journalism to keep up to date, please consider making a monthly Patreon Pledge.

Continue Reading

CBD

Columbia Care partners with international superstar Pitbull to launch N2P, a new line of full spectrum CBD wellness products — Greenway Magazine

Published

on

Designed for those with a health and wellness focus, the new line harnesses all of the power of the hemp plant for an enhanced experience and is now available online and at select Columbia Care pharmacies

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced growers, manufacturers, and distributors of cannabis and from Hemp-derived CBD products in the United States and international superstar Pitbull today announced the launch of N2P – a new line of high-quality, full-spectrum CBD products for those looking to incorporate CBD into their health and wellness routines. N2P tries to change the negative perception of CBD products and to put the potential of these products in a positive light, what N2P stands for: negative to positive.

“We are committed to changing the way people talk about CBD and offering a line of products that people can trust and expect to get the best experience possible,” said Jesse Channon, Columbia Care’s chief growth officer. “We are because of his passion entered into a partnership with Pitbull for CBD and its high quality. Together we are working to introduce premium full-spectrum CBD products for customers who are passionate about health and wellness, but also for those who are curious about CBD and have not tried it before – we want everyone to be able to change negatively too positive. “

The N2P product line has been formulated with quality in mind. These products are made from natural hemp grown in the USA and are specifically designed to use the plant’s full potential to support daily well-being, such as: The first product offering includes lip balms, ointments, tinctures and sour gums. Chocolate products will hit the market later in 2021.

“I am honored to be partnering with Columbia Care to announce our new line of CBD, N2P (Negative to Positive),” said Armando Christian Perez (Pitbull). “N2P is an all natural, high quality product that is geared towards the therapeutic benefits of CBD. It’s designed to help clients stay focused, positive, and feel at their best. Our goal is to change the perception of the health and wellness benefits of CBD products. We look forward to sharing N2P with fans around the world, Dale! “

At the start, the N2P line includes:

  • 3-pack Pina Colada lip balm (150mg CBD, 50mg per balm)
  • 2oz Relief Ointment (250mg CBD)
  • 1oz star fruit tincture (1,000 mg CBD, 33.3 mg CBD per serving)
  • 30ct. Gums (750 mg CBD, 25 mg per gum)

N2P products will be available to purchase online in select states at www.n2pwellness.com and at select Columbia Care pharmacies in Delaware, Maryland and New York. They’ll also be available at The Green Solution pharmacies in Colorado later this year.

About Columbia Care

Columbia Care is one of the largest and most experienced breeders, manufacturers, and providers of cannabis products and related services licensed in 18 US jurisdictions and the EU. Columbia Care operates 130 facilities including 99 pharmacies and 31 cultivation and manufacturing facilities, including those under development. Columbia Care is one of the original medical cannabis suppliers in the United States and now provides industry leading products and services to both the medical and adult markets. In 2021, the company launched Cannabist, its new retail brand, and created a national pharmacy network using proprietary technology platforms. The company offers products made from flowers, edibles, oils and tablets, and makes popular brands such as Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber and Platinum Label CBD. For more information on Columbia Care, please visit www.col-care.com.

Beware of forward-looking statements

This press release contains certain statements that constitute forward-looking information within the meaning of applicable securities laws and that reflect the company’s current expectations about future events. The Company has made assumptions about its ability to execute brand and product initiatives that, while deemed appropriate by the Company, may prove to be incorrect and subject to known and unknown risks and uncertainties that will lead to actual results, performance or accomplishments The company could differ materially from those expressed or implied in any forward-looking information. Securityholders should review the risk factors discussed under “Risk Factors” on the Columbia Care Annual Information Form dated March 31, 2021, filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com and described from time to time in documents submitted by. the company will be filed with the Canadian securities regulators.

Continue Reading
Advertisement

Trending